Public trial registry of the CCC-Munich

Trial Ember 2

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Ember 2
World
Full title
:

Eine Open-Label-Studie der Phase 1 im präoperativen Fenster zur Bewertung der biologischen Wirkungen von LY3484356 bei postmenopausalen Frauen mit Östrogenrezeptor-positivem, HER2-negativem Brustkrebs im Stadium I-III

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Frauenklinik IN, Telefon: 089440054111
Indications
Classification Code Description
- Breastcancer
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
I
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2022-10-17 / Unknown
Participants
Function Prename Surname Organization
World Principal Investigator NADIA HARBECK Keine Organisationseinheit angegeben Magnifier